Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammation and Alzheimer's disease pathogenesis

J Rogers1, S Webster, L F Lue

  • 1Sun Health Research Institute, Sun City, AZ 85372, USA.

Neurobiology of Aging
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for D0-D0 mixing.

Physical review letters·2007
Same author

Evidence of a broad structure at an invariant mass of 4.32 GeV/c2 in the reaction e+e- --> pi+pi-psi(2S) measured at BABAR.

Physical review letters·2007
Same author

J/psi production versus transverse momentum and rapidity in p+p collisions at square root s=200 GeV.

Physical review letters·2007
Same author

J/psi production versus centrality, transverse momentum, and rapidity in Au+Au collisions at square root sNN=200 GeV.

Physical review letters·2007
Same author

System size and energy dependence of jet-induced hadron pair correlation shapes in Cu+Cu and Au+Au collisions at square root sNN=200 and 62.4 GeV.

Physical review letters·2007
Same author

Observation of CP violation in B(0) --> K(+)pi(-) and B(0) --> pi(+)pi(-).

Physical review letters·2007
Same journal

Amygdala and hippocampal volumes as neural correlates of resilience and loneliness in older adults.

Neurobiology of aging·2026
Same journal

Hippocampal-cortical structural networks in the progression of cognitive impairment: A source-based morphometry analysis in individuals with subjective cognitive decline, mild cognitive impairment and Alzheimer's disease.

Neurobiology of aging·2026
Same journal

Brain structure in the cingulate cortex and locus coeruleus in late life is associated with engagement in complex mental activities across the life span.

Neurobiology of aging·2026
Same journal

Age-related differences in motor learning, sensorimotor neurochemistry, and cortical reactivity co-occur but are dissociated.

Neurobiology of aging·2026
Same journal

How cognition and hearing-related measures covary with hippocampal subfield features from structural MRI in younger and older adults.

Neurobiology of aging·2026
Same journal

Decreased awareness of cognitive decline is associated with multimodal Alzheimer's disease biomarkers in cognitively unimpaired individuals.

Neurobiology of aging·2026
See all related articles

Inflammation plays a key role in Alzheimer's disease (AD) pathogenesis, potentially causing neurodegeneration and benefiting from anti-inflammatory treatments. This review challenges misconceptions about inflammation's role in AD progression.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Misconceptions regarding inflammation's role in Alzheimer's disease (AD) pathogenesis hinder understanding.
  • Inflammation is often viewed as secondary to neurodegeneration or merely clearing debris.

Purpose of the Study:

  • To reassess the role of inflammatory mediators in Alzheimer's disease (AD) pathogenesis.
  • To challenge the notion that neurodegenerative mechanisms must be primary to be significant.
  • To investigate if inflammation is a necessary or sufficient cause of AD neurodegeneration.

Main Methods:

  • Review of existing literature on inflammatory molecules and mechanisms in the AD brain.
  • Analysis of retrospective and direct clinical trials of anti-inflammatory medications in AD patients.

Related Experiment Videos

Main Results:

  • Inflammatory molecules and mechanisms are significantly elevated in the AD brain.
  • Evidence suggests inflammation may be a necessary component of AD pathogenesis.
  • Inflammation may be sufficient to cause neurodegeneration in AD.
  • Clinical trials indicate anti-inflammatory drugs may slow AD progression or delay onset.

Conclusions:

  • Inflammation is a critical factor in Alzheimer's disease pathogenesis, not just a response to it.
  • Targeting inflammatory pathways with anti-inflammatory medications shows therapeutic potential for AD.